Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 28, 2026

ServiceNow Reports Fourth Quarter and Full-Year 2025 Financial Results; Board of Directors Authorizes Additional $5B for Share Repurchase Program

View original at finance.yahoo.com
ServiceNow Reports Fourth Quarter and Full-Year 2025 Financial Results; Board of Directors Authorizes Additional $5B for Share Repurchase Program ServiceNow exceeds guidance across all Q4 2025 topline growth and profitability metrics Subscription revenues of $3,466 million in Q4 2025, representing 21% year-over-year gr…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • With consistent Rule of 55+ profile, there is no AI company in the enterprise better positioned for sustainable profitable revenue growth than ServiceNow

    80% confidence
  • ServiceNow had substantial growth in licensed users, workflows, and transactions on platform

    80% confidence
  • ServiceNow is building the AI control tower for business reinvention so enterprises can operate securely in an agentic AI world

    80% confidence
  • ServiceNow strategy with disciplined focus on margin expansion remains unchanged, but ambition is higher and confidence in sustained high organic growth has never been greater

    80% confidence
  • Transactions greater than $1M net new ACV reached 244, representing nearly 40% year-over-year growth

    80% confidence
  • Customers with greater than $5M ACV reached 603, approximately 20% year-over-year growth

    80% confidence
  • ServiceNow significantly beat Q4 expectations, accelerated net new business, and issued exceptional guidance for 2026

    80% confidence
  • Armis acquisition expected to 3x+ security/risk market opportunity

    80% confidence
  • Now Assist net new ACV more than doubled year-over-year in Q4 2025

    80% confidence
  • Q4 was another strong quarter, concluding a remarkable year of AI innovation

    80% confidence
  • Recent strategic acquisitions create enormous new market opportunities and solidify ability to put AI to work securely across every corner of the enterprise

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com